Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Motala – page 11

186 clinical trials in Motala, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Motala at a glance
186
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

186 trials in Motala

Open in trial search

Follicular lymphoma

Not recruiting

Phase II Study of ME-401, Rituximab and Bendamustine as First‑Line Treatment for High‑Risk and Low‑Risk Follicular Lymphoma Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Bendamustine
  • Sponsor:Karolinska University Hospital

A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Breast cancer+1

Not recruiting

Study of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

Colitis ulcerative

Not recruiting

Comparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Herpes zoster

Not recruiting

Study on Long-Term Effects and Safety of Herpes Zoster Vaccine with Recombinant Varicella Zoster Virus Glycoprotein E in Older Adults

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Recombinant Varicella Zoster Virus Glycoprotein E
  • Sponsor:GlaxoSmithKline Biologicals

Obesity

Not recruiting

Study on the Effects of EMP16 and Ispaghula Husk for Obesity in Adults

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Acarbose
  • Sponsor:Empros Pharma AB
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Substances:Sodium Chloride
  • Sponsor:Linkopings Universitet

Gambling disorder

Not recruiting

Study of Ghrelin's Effects on Decision-Making and Gambling Behavior in Healthy Adults: Comparison with Placebo

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Substances:Lenomorelin
  • Sponsor:Linkopings Universitet

Study on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis

Investigational
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Tolebrutinib
  • Sponsor:Genzyme Corp.

Study on Durvalumab and Stereotactic Body Radiotherapy for Patients with Early-Stage Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Vastra Gotalandsregionen

IgA nephropathy

Not recruiting

Study on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Iptacopan
  • Sponsor:Novartis Pharma AG

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Motala

What the registry says about research in the country

01 Orthopedic Research

Innovative research focusing on reducing infection risks in hip arthroplasty through the evaluation of antibiotic-impregnated bone grafts. This groundbreaking study aims to enhance patient outcomes in joint replacement procedures.

  • Prosthetic Joint Infection Prevention
  • Bone Graft Technology
  • Surgical Innovation

The research explores advanced infection prevention strategies in orthopedic surgeries.

02 Wound Care Management

Clinical investigation comparing antimicrobial treatments for diabetic foot ulcers, evaluating the effectiveness of different therapeutic agents in wound healing processes.

  • Diabetic Wound Care
  • Antimicrobial Therapy
  • Healing Time Assessment

This research aims to improve treatment outcomes for patients with chronic diabetic wounds.

03 Neurology Studies

Advanced research into Primary Progressive Multiple Sclerosis treatment, examining innovative therapeutic approaches using BTK inhibitors to delay disease progression.

  • Multiple Sclerosis Treatment
  • Neurological Disease Management
  • Disability Progression Control

The study focuses on breakthrough treatments for progressive neurological conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.